Is myopathy a side effect of LAMIVUDINE ? ( FactMed.com )

About this FactMed analysis covering adverse side effect reports of LAMIVUDINE patients who developed myopathy.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 90 individuals taking LAMIVUDINE reported myopathy to the FDA. A total of 10196 LAMIVUDINE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between LAMIVUDINE and myopathy. In doing so, we compare LAMIVUDINE with other drugs that cause myopathy, to help you evaluate whether or not LAMIVUDINE causes myopathy. Likewise, this page shows the most highly-reported side effects of LAMIVUDINE, so you can see if myopathy ranks among LAMIVUDINE's most well-known side effects.

Summary Statistics
Reports of LAMIVUDINE causing myopathy: 90
Reports of any side effect of LAMIVUDINE : 10196
Percentage of LAMIVUDINE patients where myopathy is a reported side effect: 0.8827%

FDA reports of any drug causing myopathy : 3605
Average percentage for all medicated patients where myopathy is reported as a complication: 0.0226%

Physician opinion on LAMIVUDINE as adverse event culprit:

Overall opinion for all reports of this drug:

Most frequent diagnoses/indications for prescribing LAMIVUDINE:

HIV INFECTION ( 4699 patients )
HEPATITIS B ( 426 patients )
DRUG USE FOR UNKNOWN INDICATION ( 292 patients )
ANTIRETROVIRAL THERAPY ( 279 patients )
ACQUIRED IMMUNODEFICIENCY SYNDROME ( 187 patients )
PROPHYLAXIS ( 155 patients )
DRUG EXPOSURE DURING PREGNANCY ( 144 patients )
ANTIVIRAL PROPHYLAXIS ( 143 patients )
HIV TEST POSITIVE ( 118 patients )
HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION ( 111 patients )
PROPHYLAXIS AGAINST HIV INFECTION ( 100 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 89 patients )
SYSTEMIC ANTIVIRAL TREATMENT ( 40 patients )
RETROVIRAL INFECTION ( 26 patients )
ANTIVIRAL TREATMENT ( 24 patients )
HEPATIC CIRRHOSIS ( 23 patients )
HEPATITIS ( 22 patients )
MATERNAL EXPOSURE DURING PREGNANCY ( 19 patients )
HEPATITIS C ( 18 patients )
HEPATITIS B VIRUS ( 12 patients )
BLOOD HIV RNA ( 9 patients )
CHRONIC HEPATITIS ( 8 patients )
HIV INFECTION CDC CATEGORY C3 ( 8 patients )
VIRAL INFECTION ( 8 patients )
ACUTE HIV INFECTION ( 7 patients )
MATERNAL EXPOSURE TIMING UNSPECIFIED ( 6 patients )
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY ( 6 patients )
ILL-DEFINED DISORDER ( 5 patients )
HEPATITIS B VIRUS TEST ( 4 patients )
IMMUNOSUPPRESSION ( 4 patients )
ADVERSE EVENT ( 4 patients )
HIV INFECTION CDC CATEGORY A1 ( 4 patients )
LIPODYSTROPHY ACQUIRED ( 3 patients )
EXPOSURE TO COMMUNICABLE DISEASE ( 3 patients )
ANTIFUNGAL PROPHYLAXIS ( 3 patients )
VIRAL HEPATITIS CARRIER ( 3 patients )
HEPATITIS B ANTIGEN POSITIVE ( 3 patients )
HIV INFECTION WHO CLINICAL STAGE I ( 3 patients )
HEPATITIS B VIRUS TEST POSITIVE ( 3 patients )
HIV INFECTION CDC CATEGORY B2 ( 3 patients )
PRIMARY EFFUSION LYMPHOMA ( 3 patients )
HEPATITIS B SURFACE ANTIGEN POSITIVE ( 2 patients )
HIV INFECTION WHO CLINICAL STAGE II ( 2 patients )
RENAL TRANSPLANT ( 2 patients )
TROPICAL SPASTIC PARESIS ( 2 patients )
VERTICAL INFECTION TRANSMISSION ( 2 patients )
PNEUMOCYSTIS JIROVECI INFECTION ( 2 patients )
HEPATITIS ACUTE ( 2 patients )
KAPOSI'S SARCOMA ( 2 patients )
ASCITES ( 2 patients )
HIV INFECTION CDC CATEGORY B3 ( 2 patients )
CD4 LYMPHOCYTES DECREASED ( 2 patients )
HEPATITIS B POSITIVE ( 2 patients )
LIVER DISORDER ( 2 patients )
LIVER TRANSPLANT ( 2 patients )
END STAGE AIDS ( 2 patients )
HYPOKALAEMIA ( 2 patients )
HIV CARRIER ( 2 patients )
NON-HODGKIN'S LYMPHOMA ( 2 patients )
IMMUNODEFICIENCY ( 2 patients )
INTENTIONAL SELF-INJURY ( 2 patients )
HEPATITIS B E ANTIGEN POSITIVE ( 1 patients )
HIV INFECTION CDC GROUP I ( 1 patients )
LIVER INJURY ( 1 patients )
DIFFUSE LARGE B-CELL LYMPHOMA ( 1 patients )
LYMPHOMA ( 1 patients )
DRUG EXPOSURE VIA BREAST MILK ( 1 patients )
AIDS RELATED COMPLICATION ( 1 patients )
HIV ANTIGEN POSITIVE ( 1 patients )
MYCOBACTERIUM AVIUM COMPLEX INFECTION ( 1 patients )
PATHOGEN RESISTANCE ( 1 patients )
HEPATIC NEOPLASM MALIGNANT ( 1 patients )
HIV INFECTION CDC CATEGORY A3 ( 1 patients )
LIPIDS ABNORMAL ( 1 patients )
DIALYSIS ( 1 patients )
RASH ( 1 patients )
HIV INFECTION WHO CLINICAL STAGE IV ( 1 patients )
MALARIA PROPHYLAXIS ( 1 patients )
DRUG LEVEL ( 1 patients )
HIV WASTING SYNDROME ( 1 patients )
THYROID CANCER ( 1 patients )
HEPATITIS VIRAL ( 1 patients )
TUBERCULOSIS ( 1 patients )
ANTI-INFECTIVE THERAPY ( 1 patients )
VIRAEMIA ( 1 patients )
PLATELET COUNT DECREASED ( 1 patients )
KAPOSI'S SARCOMA AIDS RELATED ( 1 patients )
HIV INFECTION CDC CATEGORY C1 ( 1 patients )
( 0 patients )

Drugs with high FDA adverse event association with myopathy:

LIPITOR (517 patients)
ZOCOR (480 patients)
ASPIRIN (474 patients)
SIMVASTATIN (410 patients)
FOSAMAX (309 patients)
PREDNISONE (241 patients)
CRESTOR (239 patients)
ZOMETA (201 patients)
PREDNISOLONE (199 patients)
LASIX (177 patients)
FUROSEMIDE (162 patients)
ZETIA (153 patients)
HYDROCHLOROTHIAZIDE (144 patients)
PREDNISONE TAB (139 patients)
LEVOTHYROXINE SODIUM (138 patients)
VIOXX (130 patients)
ALLOPURINOL (125 patients)
DEXAMETHASONE (124 patients)
INSULIN (120 patients)
COUMADIN (118 patients)
CYCLOSPORINE (113 patients)
ATENOLOL (112 patients)
ATORVASTATIN CALCIUM (110 patients)
NORVASC (108 patients)
CLARITHROMYCIN (107 patients)
AMBIEN (104 patients)
MYCOPHENOLATE MOFETIL (103 patients)
LISINOPRIL (99 patients)
NOROXIN (98 patients)
DECADRON (97 patients)
OMEPRAZOLE (97 patients)
POTASSIUM CHLORIDE (96 patients)
SORAFENIB (RAF KINASE INHIBITOR) (95 patients)
GABAPENTIN (94 patients)
SYNTHROID (94 patients)
LAMIVUDINE (90 patients)
AMLODIPINE (90 patients)
RAMIPRIL (89 patients)
NEXIUM (88 patients)
PRILOSEC (87 patients)
METHYLPREDNISOLONE (85 patients)
WARFARIN SODIUM (83 patients)
ZIDOVUDINE (82 patients)
ALBUTEROL (82 patients)
LANSOPRAZOLE (80 patients)
MEK INHIBITOR (DIHYDROXYPROP-DIFLU-METHOXYPHEN-CYCLOPROPA-SULFAMI) (80 patients)
PROTONIX (79 patients)
ACETAMINOPHEN (77 patients)
FOLIC ACID (77 patients)
MULTI-VITAMINS (75 patients)
XANAX (75 patients)
COZAAR (73 patients)
NEURONTIN (73 patients)
REMICADE (71 patients)
REVLIMID (69 patients)
HUMIRA (68 patients)
AMIODARONE HCL (67 patients)
FLONASE (65 patients)
CELEXA (64 patients)
FERROUS SULFATE TAB (64 patients)
ATORVASTATIN (64 patients)
AMLODIPINE BESYLATE (64 patients)
SPIRONOLACTONE (63 patients)
MAGNEVIST (62 patients)
VYTORIN (62 patients)
ZOLOFT (61 patients)
PEPCID (60 patients)
PROGRAF (60 patients)
CITALOPRAM HYDROBROMIDE (59 patients)
VICODIN (59 patients)
ADVAIR DISKUS 100/50 (59 patients)
ULTRAVIST 150 (59 patients)
PLAVIX (59 patients)
METHOTREXATE (58 patients)
COLCHICINE (58 patients)
AREDIA (57 patients)
OXYCONTIN (57 patients)
LYRICA (57 patients)
DIDANOSINE (56 patients)
ENALAPRIL MALEATE (55 patients)
HEPARIN SODIUM INJECTION (55 patients)
TAMOXIFEN CITRATE (55 patients)
ACYCLOVIR (52 patients)
FENOFIBRATE (52 patients)
PRAVASTATIN (52 patients)
CLONAZEPAM (51 patients)
ITRACONAZOLE (51 patients)
CYCLOPHOSPHAMIDE (51 patients)
DIGOXIN (49 patients)
SEBIVO (49 patients)
TOPROL-XL (49 patients)
LORAZEPAM (48 patients)
DILTIAZEM (48 patients)
LORTAB (48 patients)
ELAVIL (47 patients)
DIFLUCAN (47 patients)
METOPROLOL TARTRATE (46 patients)
ATIVAN (46 patients)
VELCADE (45 patients)
ALENDRONATE SODIUM (45 patients)
VITAMIN D (45 patients)
KLOR-CON (45 patients)
PRAVACHOL (45 patients)
WELLBUTRIN (44 patients)
TRICOR (44 patients)
DARVOCET-N 100 (44 patients)
PERCOCET (44 patients)
RAPAMUNE (43 patients)
ASCORBIC ACID (43 patients)
LEVAQUIN (43 patients)
AROMASIN (43 patients)
DIAZEPAM (43 patients)
ZANTAC (43 patients)
GEMFIBROZIL (41 patients)
CELEBREX (41 patients)
OXYCODONE HCL (41 patients)
ABACAVIR (40 patients)
LEXAPRO (40 patients)
NIFEDIPINE (40 patients)
RADIATION THERAPY (39 patients)
ACETYLSALICYLIC ACID SRT (39 patients)
ACIPHEX (39 patients)
METFORMIN HCL (39 patients)
IRON (39 patients)
ALTACE (39 patients)
TACROLIMUS (38 patients)
EFAVIRENZ (38 patients)
ZYPREXA (38 patients)
ZYRTEC (38 patients)
LESCOL (37 patients)
[THERAPY UNSPECIFIED] (37 patients)
METOPROLOL (37 patients)
GLEEVEC (37 patients)
PANTOPRAZOLE SODIUM (36 patients)
FOSAMAX PLUS D (36 patients)
PROPRANOLOL HYDROCHLORIDE (36 patients)
EFFEXOR (36 patients)
AMIODARONE (36 patients)
CEFTRIAXONE (36 patients)
HERCEPTIN (35 patients)
THALIDOMIDE (35 patients)
FUSIDIC ACID (35 patients)
SINGULAIR (35 patients)
IBUPROFEN (35 patients)
SPIRIVA (35 patients)
LOSARTAN POTASSIUM (35 patients)
VANCOMYCIN (35 patients)
WARFARIN (34 patients)
PERIDEX (34 patients)
BISOPROLOL (34 patients)
HYZAAR (34 patients)
SIROLIMUS (34 patients)
SOLU-MEDROL (34 patients)
ALPRAZOLAM (34 patients)
CO-TRIMOXAZOLE (34 patients)
AMITRIPTYLINE HCL (34 patients)
COREG (34 patients)
VITAMINS (UNSPECIFIED) (33 patients)
ACETYLSALICYLIC ACID (33 patients)
AZATHIOPRINE (33 patients)
ZOFRAN (33 patients)
CALTRATE +D (33 patients)
PROTEINASE INHIBITORS (33 patients)
CARTIA /USA/ (33 patients)
NIASPAN (33 patients)
PANTOPRAZOLE (33 patients)
MEGESTROL ACETATE (32 patients)
COMPAZINE (32 patients)
ADENOSINE (32 patients)
ALDACTONE (32 patients)
LANTUS (32 patients)
GASMOTIN (32 patients)
PROZAC (32 patients)
ARIMIDEX (31 patients)
AVELOX (31 patients)
FENTANYL (31 patients)
CALCIUM (UNSPECIFIED) (31 patients)
PAXIL (31 patients)
GLIPIZIDE (31 patients)
FLUCONAZOLE (31 patients)
ARANESP (31 patients)
CLARITIN (31 patients)
DILAUDID (31 patients)
NEUPOGEN (31 patients)
AVANDIA (31 patients)
B12 ^RECIP^ (30 patients)
K-DUR (30 patients)
CALCIUM CARBONATE (30 patients)
CELLCEPT (30 patients)
METFORMIN (30 patients)
CLOPIDOGREL (30 patients)
TRAMADOL HCL (30 patients)
REQUIP (29 patients)
CARVEDILOL (29 patients)
GLUCOPHAGE (29 patients)
FLOMAX (29 patients)
ZESTRIL (29 patients)
MIRTAZAPINE (29 patients)
TIAZAC (29 patients)
CAPECITABINE (29 patients)
KETEK (29 patients)
NICORANDIL (29 patients)
VERAPAMIL (29 patients)
CYMBALTA (28 patients)
RALTEGRAVIR (28 patients)
LOVASTATIN (28 patients)
CALCIUM (28 patients)
ACTOS (28 patients)
MICARDIS (28 patients)
DILTIAZEM HYDROCHLORIDE (28 patients)

Most common side effects for patients taking LAMIVUDINE:

PYREXIA (775 patients)
IMMUNE RECONSTITUTION SYNDROME (753 patients)
DRUG EXPOSURE DURING PREGNANCY (660 patients)
VOMITING (593 patients)
NAUSEA (583 patients)
DIARRHOEA (533 patients)
ANAEMIA (529 patients)
ALANINE AMINOTRANSFERASE INCREASED (417 patients)
DRUG INTERACTION (400 patients)
DRUG INEFFECTIVE (312 patients)
RENAL FAILURE ACUTE (309 patients)
HYPERLIPIDAEMIA (309 patients)
ABDOMINAL PAIN (303 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (298 patients)
WEIGHT DECREASED (294 patients)
HEPATIC FUNCTION ABNORMAL (291 patients)
DYSPNOEA (282 patients)
RASH (279 patients)
RENAL FAILURE (278 patients)
LYMPHADENOPATHY (277 patients)
HEADACHE (277 patients)
DEATH (274 patients)
JAUNDICE (261 patients)
ASTHENIA (258 patients)
MALAISE (255 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (254 patients)
BLOOD BILIRUBIN INCREASED (253 patients)
LIPODYSTROPHY ACQUIRED (247 patients)
HEPATIC FAILURE (245 patients)
PNEUMONIA (238 patients)
LACTIC ACIDOSIS (235 patients)
NEUTROPENIA (235 patients)
SEPSIS (234 patients)
HEPATITIS B (230 patients)
DRUG RESISTANCE (229 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (223 patients)
DIZZINESS (223 patients)
COUGH (222 patients)
FATIGUE (220 patients)
CONFUSIONAL STATE (214 patients)
RENAL IMPAIRMENT (213 patients)
PREMATURE BABY (210 patients)
HAEMOGLOBIN DECREASED (200 patients)
PREGNANCY (198 patients)
ASCITES (195 patients)
HYPERTENSION (185 patients)
DRUG TOXICITY (179 patients)
LIVER DISORDER (175 patients)
BLOOD TRIGLYCERIDES INCREASED (174 patients)
PANCYTOPENIA (173 patients)
THROMBOCYTOPENIA (168 patients)
HEPATIC CIRRHOSIS (166 patients)
HIV INFECTION (166 patients)
METABOLIC ACIDOSIS (160 patients)
ABDOMINAL DISTENSION (159 patients)
HEPATOTOXICITY (158 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (156 patients)
ABORTION SPONTANEOUS (155 patients)
CONDITION AGGRAVATED (155 patients)
PAIN IN EXTREMITY (155 patients)
HEPATITIS (151 patients)
HEPATOMEGALY (148 patients)
BLOOD CREATININE INCREASED (146 patients)
CONVULSION (146 patients)
DEHYDRATION (142 patients)
OEDEMA PERIPHERAL (142 patients)
MYALGIA (141 patients)
WHITE BLOOD CELL COUNT DECREASED (141 patients)
PANCREATITIS (138 patients)
MATERNAL DRUGS AFFECTING FOETUS (137 patients)
MITOCHONDRIAL TOXICITY (136 patients)
CACHEXIA (134 patients)
BLOOD LACTIC ACID INCREASED (133 patients)
ANOREXIA (132 patients)
PORTAL HYPERTENSION (130 patients)
KAPOSI'S SARCOMA (129 patients)
HEPATIC ENCEPHALOPATHY (128 patients)
TUBERCULOSIS (123 patients)
NEUROPATHY PERIPHERAL (120 patients)
DIABETES MELLITUS (119 patients)
HYPOTENSION (117 patients)
HYPERLACTACIDAEMIA (115 patients)
PAIN (115 patients)
MUSCULAR WEAKNESS (114 patients)
PNEUMOCYSTIS JIROVECI PNEUMONIA (114 patients)
TACHYCARDIA (111 patients)
LIPOATROPHY (111 patients)
RESPIRATORY FAILURE (111 patients)
HYPOKALAEMIA (110 patients)
CHOLESTASIS (110 patients)
DISEASE RECURRENCE (110 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (109 patients)
OSTEONECROSIS (108 patients)
DEPRESSION (108 patients)
PLATELET COUNT DECREASED (108 patients)
STEVENS-JOHNSON SYNDROME (108 patients)
VIRAL LOAD INCREASED (107 patients)
DECREASED APPETITE (107 patients)
AGITATION (107 patients)
RHABDOMYOLYSIS (107 patients)
MULTI-ORGAN FAILURE (105 patients)
HYPOAESTHESIA (105 patients)
ORAL CANDIDIASIS (105 patients)
ARTHRALGIA (103 patients)
LIVER FUNCTION TEST ABNORMAL (102 patients)
CAESAREAN SECTION (102 patients)
SPLENOMEGALY (100 patients)
HYPERTRIGLYCERIDAEMIA (97 patients)
LEUKOPENIA (96 patients)
DYSPHAGIA (94 patients)
BACK PAIN (94 patients)
CD4 LYMPHOCYTES DECREASED (94 patients)
ABDOMINAL PAIN UPPER (93 patients)
HEPATIC ENZYME INCREASED (93 patients)
EYELID PTOSIS (93 patients)
ACUTE HEPATIC FAILURE (92 patients)
VIRAL MUTATION IDENTIFIED (92 patients)
STILLBIRTH (91 patients)
HEPATITIS C (91 patients)
MYOPATHY (90 patients)
PROTEINURIA (89 patients)
DIPLOPIA (87 patients)
PRURITUS (87 patients)
SEPTIC SHOCK (85 patients)
GAIT DISTURBANCE (84 patients)
ABORTION INDUCED (83 patients)
SOMNOLENCE (83 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (83 patients)
NERVOUS SYSTEM DISORDER (83 patients)
GASTROENTERITIS (82 patients)
HYPERSENSITIVITY (81 patients)
INSOMNIA (81 patients)
VANISHING BILE DUCT SYNDROME (80 patients)
CARDIAC FAILURE (80 patients)
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (80 patients)
CHEST PAIN (79 patients)
STAPHYLOCOCCAL INFECTION (78 patients)
GASTROINTESTINAL DISORDER (78 patients)
TRANSAMINASES INCREASED (78 patients)
HYPERGLYCAEMIA (78 patients)
HYPERBILIRUBINAEMIA (76 patients)
HERPES ZOSTER (76 patients)
HEPATIC STEATOSIS (76 patients)
PLEURAL EFFUSION (75 patients)
RESPIRATORY DISTRESS (73 patients)
BRADYCARDIA (73 patients)
OESOPHAGEAL VARICES HAEMORRHAGE (73 patients)
TRANSPLANT REJECTION (72 patients)
PHARYNGITIS (72 patients)
MYOCARDIAL INFARCTION (71 patients)
ERYTHEMA (71 patients)
RASH MACULO-PAPULAR (71 patients)
VARICES OESOPHAGEAL (70 patients)
CHILLS (70 patients)
CONSTIPATION (70 patients)
DEEP VEIN THROMBOSIS (70 patients)
HEPATOSPLENOMEGALY (70 patients)
HYPONATRAEMIA (69 patients)
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA (69 patients)
PALPITATIONS (67 patients)
CARDIAC MURMUR (66 patients)
WEIGHT INCREASED (65 patients)
MYCOBACTERIUM AVIUM COMPLEX INFECTION (65 patients)
LYMPHOMA (64 patients)
HEPATIC NECROSIS (63 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (63 patients)
RENAL TUBULAR DISORDER (63 patients)
BLOOD AMYLASE INCREASED (63 patients)
FEBRILE NEUTROPENIA (62 patients)
TREATMENT NONCOMPLIANCE (62 patients)
BLOOD HIV RNA INCREASED (61 patients)
DRUG HYPERSENSITIVITY (61 patients)
CARDIOMYOPATHY (61 patients)
GASTRITIS (61 patients)
TACHYPNOEA (61 patients)
OESOPHAGEAL CANDIDIASIS (60 patients)
ARRHYTHMIA (59 patients)
LETHARGY (58 patients)
MATERNAL EXPOSURE DURING PREGNANCY (58 patients)
NEPHROLITHIASIS (58 patients)
BLOOD CHOLESTEROL INCREASED (58 patients)
PRODUCTIVE COUGH (58 patients)
BLOOD URIC ACID INCREASED (57 patients)
BLOOD PRESSURE DECREASED (57 patients)
NEPHROTIC SYNDROME (57 patients)
CALCULUS URINARY (57 patients)
CUSHING'S SYNDROME (55 patients)
LIVER TRANSPLANT (55 patients)
INTRA-UTERINE DEATH (55 patients)
ATRIOVENTRICULAR BLOCK COMPLETE (55 patients)
GRAFT DYSFUNCTION (54 patients)
PARAESTHESIA (54 patients)
PULMONARY EMBOLISM (54 patients)
PANCREATITIS ACUTE (54 patients)
MELAENA (53 patients)
PULMONARY TUBERCULOSIS (53 patients)
PULMONARY HYPERTENSION (53 patients)
MENINGITIS CRYPTOCOCCAL (53 patients)
OVERDOSE (53 patients)
HYPERKALAEMIA (52 patients)
NEPHRITIS INTERSTITIAL (52 patients)
RENAL DISORDER (52 patients)
BLOOD GLUCOSE INCREASED (52 patients)
MITOCHONDRIAL CYTOPATHY (51 patients)
COAGULOPATHY (51 patients)
SMALL FOR DATES BABY (51 patients)
HYPOPHOSPHATAEMIA (51 patients)
PORTAL VEIN THROMBOSIS (50 patients)
INFLUENZA LIKE ILLNESS (50 patients)
HEPATIC NEOPLASM MALIGNANT (50 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.

Recent FactMed Activity for LAMIVUDINE

Issue	Description / Topic	Timestamp
QUESTION STAPHYLOCOCCAL INFECTION	Can a staph patient be treated with lamivudine... And does it has side effectCan a staph patient be treated with lamivudine... And does it has side effect???	2015-05-09 12:50:39
QUESTION FEEDING DISORDER NEONATAL	We have had several coetmnms to this post from mothers whose babies are taking Nevirapine, asking for advice. This is not an appropriate forum for giving medical advice. If you have concerns about your baby's health, we suggest you visit the nearest clinic (preferably the same place where you obtained the antiretrovirals for you and your baby) to consult with a health professional.	2016-02-13 15:48:44
QUESTION TINNITUS	I'v been taking lamuvidin for the past 4 months but resently i started hearing unconfortable sounds in my left ear. I wonder if there is any relationship with the medicine(lamuvidin) i'v been taking?	2016-12-15 10:55:11

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about myopathy and LAMIVUDINE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.

Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking LAMIVUDINE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.

Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in LAMIVUDINE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.

We are currently accepting registration for LAMIVUDINE experts. If you are a healthcare provider experienced in prescribing LAMIVUDINE, please register here.